PTCT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $44,668,298.43

PTC Therapeutics Insider Trading History Chart

PTC Therapeutics Share Price & Price History

^$65.30

▼ -1.77 (-2.64%)

As of 03/20/2026 05:00 PM ET

Days: 30 | 90 | 365

PTC Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/12/2026	Matthew B. Klein	CEO	Sell	2,662	$64.08	$170,580.96	396,920
3/10/2026	Stephanie S. Okey	Director	Sell	15,167	$70.00	$1,061,690.00	8,000
3/5/2026	Lee Scott Golden	EVP	Sell	10,000	$63.38	$633,800.00	79,944
3/5/2026	Neil Gregory Almstead	Insider	Sell	3,989	$63.38	$252,822.82	2,737
3/5/2026	Stephanie S. Okey	Director	Sell	6,333	$63.38	$401,385.54	8,000
2/19/2026	Mark Elliott Boulding	VP	Sell	3,019	$69.48	$209,760.12	105,212
2/18/2026	Christine Marie Utter	CAO	Sell	2,494	$69.36	$172,983.84	70,199
2/18/2026	Eric Pauwels	Insider	Sell	3,019	$69.36	$209,397.84	77,122
2/18/2026	Lee Scott Golden	EVP	Sell	2,484	$69.36	$172,290.24	89,944
2/18/2026	Mark Elliott Boulding	VP	Sell	3,081	$69.36	$213,698.16	108,231
2/18/2026	Matthew B. Klein	CEO	Sell	7,371	$69.36	$511,252.56	387,082
2/18/2026	Neil Gregory Almstead	Insider	Sell	3,056	$69.36	$211,964.16	112,140
2/18/2026	Neil Gregory Almstead	Insider	Sell	65	$69.36	$4,508.40	6,726
2/18/2026	Pierre Gravier	CFO	Sell	2,992	$69.36	$207,525.12	87,318
2/17/2026	Mark Elliott Boulding	VP	Sell	2,813	$69.29	$194,912.77	111,312
1/12/2026	Eric Pauwels	Insider	Sell	1,024	$78.70	$80,588.80	80,141
1/9/2026	Eric Pauwels	Insider	Sell	1,722	$77.41	$133,300.02	81,165
1/9/2026	Mark Elliott Boulding	VP	Sell	2,314	$77.93	$180,330.02	111,312
1/8/2026	Christine Marie Utter	CAO	Sell	1,034	$76.45	$79,049.30	72,693
1/8/2026	Eric Pauwels	Insider	Sell	4,602	$76.50	$352,053.00	82,887
1/8/2026	Lee Scott Golden	EVP	Sell	866	$76.45	$66,205.70	92,428
1/8/2026	Mark Elliott Boulding	VP	Sell	4,033	$76.56	$308,766.48	113,626
1/8/2026	Matthew B. Klein	CEO	Sell	2,514	$76.45	$192,195.30	394,453
1/8/2026	Neil Gregory Almstead	Insider	Sell	881	$76.45	$67,352.45	115,196
1/8/2026	Neil Gregory Almstead	Insider	Sell	59	$76.45	$4,510.55	6,791
1/7/2026	Christine Marie Utter	CAO	Sell	1,235	$77.45	$95,650.75	73,727
1/7/2026	Eric Pauwels	Insider	Sell	1,352	$77.48	$104,752.96	87,489
1/7/2026	Lee Scott Golden	EVP	Sell	642	$77.48	$49,742.16	93,294
1/7/2026	Mark Elliott Boulding	VP	Sell	4,879	$77.44	$377,829.76	117,659
1/7/2026	Matthew B. Klein	CEO	Sell	3,016	$77.48	$233,679.68	396,967
1/7/2026	Neil Gregory Almstead	Insider	Sell	1,026	$77.48	$79,494.48	116,077
1/7/2026	Neil Gregory Almstead	Insider	Sell	52	$77.48	$4,028.96	6,850
1/6/2026	Christine Marie Utter	CAO	Sell	1,381	$76.95	$106,267.95	74,962
1/6/2026	Eric Pauwels	Insider	Sell	1,789	$76.95	$137,663.55	88,841
1/6/2026	Lee Scott Golden	EVP	Sell	1,340	$76.95	$103,113.00	93,936
1/6/2026	Mark Elliott Boulding	VP	Sell	1,739	$76.95	$133,816.05	119,162
1/6/2026	Matthew B. Klein	CEO	Sell	5,149	$76.95	$396,215.55	399,983
1/6/2026	Neil Gregory Almstead	Insider	Sell	1,279	$76.95	$98,419.05	117,103
1/6/2026	Neil Gregory Almstead	Insider	Sell	54	$76.95	$4,155.30	6,902
1/6/2026	Pierre Gravier	CFO	Sell	2,139	$76.95	$164,596.05	90,310
1/5/2026	Emma Reeve	Director	Sell	734	$76.00	$55,784.00	10,666
1/5/2026	Mark Elliott Boulding	VP	Sell	2,266	$75.55	$171,196.30	120,901
1/2/2026	Glenn Md Phd Steele Jr	Director	Sell	12,000	$76.35	$916,200.00	18,500
12/30/2025	Matthew B. Klein	CEO	Sell	8,089	$76.64	$619,940.96	341,875
12/19/2025	Eric Pauwels	Insider	Sell	20,508	$77.26	$1,584,448.08	70,373
12/18/2025	Eric Pauwels	Insider	Sell	3,202	$75.06	$240,342.12	70,373
12/17/2025	Eric Pauwels	Insider	Sell	40,290	$75.43	$3,039,074.70	70,373
12/3/2025	Emma Reeve	Director	Sell	733	$78.62	$57,628.46	6,666
12/2/2025	Matthew B. Klein	CEO	Sell	3,428	$79.07	$271,051.96	349,964
11/25/2025	Allan Steven Jacobson	Director	Sell	14,199	$83.55	$1,186,326.45	17,451
11/25/2025	Neil Gregory Almstead	Insider	Sell	71,928	$83.44	$6,001,672.32	100,625
11/24/2025	Allan Steven Jacobson	Director	Sell	11,801	$80.14	$945,732.14	17,451
11/24/2025	Neil Gregory Almstead	Insider	Sell	35,572	$80.18	$2,852,162.96	100,625
11/21/2025	Emma Reeve	Director	Sell	10,000	$79.50	$795,000.00	6,666
11/17/2025	Mark Elliott Boulding	VP	Sell	2,812	$75.99	$213,683.88	103,901
11/12/2025	Emma Reeve	Director	Sell	7,333	$74.50	$546,308.50	6,666
10/30/2025	Emma Reeve	Director	Sell	15,666	$69.50	$1,088,787.00	6,666
10/7/2025	Mark Elliott Boulding	VP	Sell	3,375	$63.43	$214,076.25	103,901
10/6/2025	Mark Elliott Boulding	VP	Sell	2,266	$65.07	$147,448.62	103,901
10/3/2025	Allan Steven Jacobson	Director	Sell	12,000	$65.00	$780,000.00	17,451
10/3/2025	Emma Reeve	Director	Sell	25,562	$65.96	$1,686,069.52	10,332
10/3/2025	Mark Elliott Boulding	VP	Sell	22,655	$65.82	$1,491,152.10	103,901
10/3/2025	Neil Gregory Almstead	Insider	Sell	55,000	$66.05	$3,632,750.00	100,625
9/12/2025	Mark Elliott Boulding	VP	Sell	24,585	$61.34	$1,508,043.90	103,901
9/11/2025	Emma Reeve	Director	Sell	15,705	$59.50	$934,447.50	10,332
9/11/2025	Mark Elliott Boulding	VP	Sell	22,664	$61.00	$1,382,504.00	103,901
9/9/2025	David P. Southwell	Director	Sell	12,000	$58.34	$700,080.00	16,850
9/8/2025	Eric Pauwels	Insider	Sell	39,850	$56.92	$2,268,262.00	72,912
8/28/2025	Allan Steven Jacobson	Director	Sell	1,667	$50.15	$83,600.05	17,451
8/28/2025	Allan Steven Jacobson	Director	Sell	1,667	$50.15	$83,600.05	17,451
8/5/2025	Matthew B. Klein	CEO	Sell	10,739	$51.74	$555,635.86	337,767
7/15/2025	Pierre Gravier	CFO	Sell	2,516	$49.46	$124,441.36	71,920
5/16/2025	Mark Elliott Boulding	VP	Sell	883	$46.02	$40,635.66	103,901
5/15/2025	Mark Elliott Boulding	VP	Sell	1,929	$46.18	$89,081.22	103,901
4/22/2025	Matthew B. Klein	CEO	Sell	2,804	$48.74	$136,666.96	273,234
4/2/2025	Lee Scott Golden	EVP	Sell	897	$46.95	$42,114.15	75,997
3/13/2025	Stephanie S. Okey	Director	Sell	5,000	$54.00	$270,000.00	8,867
3/12/2025	Mark Elliott Boulding	VP	Sell	15,521	$53.30	$827,269.30	103,901
3/4/2025	Allan Steven Jacobson	Director	Sell	1,230	$51.52	$63,369.60	19,118
2/19/2025	Christine Marie Utter	CAO	Sell	879	$50.10	$44,037.90	63,442
2/19/2025	Eric Pauwels	CEO	Sell	1,378	$50.10	$69,037.80	85,427
2/19/2025	Lee Scott Golden	EVP	Sell	795	$50.10	$39,829.50	77,856
2/19/2025	Mark Elliott Boulding	VP	Sell	1,333	$50.10	$66,783.30	105,515
2/19/2025	Neil Gregory Almstead	Insider	Sell	1,300	$50.10	$65,130.00	101,931
2/19/2025	Pierre Gravier	CFO	Sell	1,168	$50.10	$58,516.80	75,603
1/7/2025	Christine Marie Utter	CAO	Sell	1,291	$45.34	$58,533.94	65,983
1/7/2025	Eric Pauwels	CEO	Sell	1,599	$45.34	$72,498.66	88,941
1/7/2025	Lee Scott Golden	EVP	Sell	810	$45.34	$36,725.40	79,849
1/7/2025	Mark Elliott Boulding	VP	Sell	1,543	$45.34	$69,959.62	108,846
1/7/2025	Neil Gregory Almstead	Insider	Sell	1,265	$45.34	$57,355.10	104,783
12/31/2024	Matthew B. Klein	CEO	Sell	8,279	$45.16	$373,879.64	217,528
12/2/2024	Christine Marie Utter	CAO	Sell	17,800	$51.77	$921,506.00	52,428
12/2/2024	Jerome B. Zeldis	Director	Sell	24,000	$51.50	$1,236,000.00	14,500
12/2/2024	Mark Elliott Boulding	VP	Sell	85,600	$52.26	$4,473,456.00	92,389
12/2/2024	Neil Gregory Almstead	Insider	Sell	69,550	$52.06	$3,620,773.00	86,202
7/16/2024	Pierre Gravier	CFO	Sell	2,269	$34.02	$77,191.38	53,531
5/22/2024	Jerome B. Zeldis	Director	Sell	20,000	$38.24	$764,800.00	14,500
5/7/2024	Lee Scott Golden	EVP	Sell	175	$32.82	$5,743.50	59,813
4/19/2024	Matthew B. Klein	CEO	Sell	3,361	$24.89	$83,655.29	225,807
4/17/2024	Eric Pauwels	CEO	Sell	787	$25.14	$19,785.18	67,694
4/2/2024	Lee Scott Golden	EVP	Sell	526	$28.37	$14,922.62	59,988
1/30/2024	Christine Marie Utter	CAO	Sell	318	$27.25	$8,665.50	35,528
1/30/2024	Mark Elliott Boulding	VP	Sell	794	$27.25	$21,636.50	71,189
1/30/2024	Neil Gregory Almstead	Insider	Sell	618	$27.25	$16,840.50	61,202
1/22/2024	Allan Steven Jacobson	Director	Sell	10,000	$27.38	$273,800.00	12,348
1/8/2024	Christine Marie Utter	CAO	Sell	1,188	$28.64	$34,024.32	37,499
1/8/2024	Eric Pauwels	Insider	Sell	1,569	$28.64	$44,936.16	46,612
1/8/2024	Mark Elliott Boulding	VP	Sell	1,457	$28.64	$41,728.48	73,921
1/8/2024	Matthew B. Klein	CEO	Sell	2,237	$28.64	$64,067.68	165,918
1/8/2024	Michael Schmertzler	Director	Sell	1,500	$27.81	$41,715.00	115,266
1/5/2024	Matthew B. Klein	CEO	Sell	10,107	$27.15	$274,405.05	168,155
12/12/2023	Pierre Gravier	CFO	Buy	7,700	$25.81	$198,737.00	33,700
9/6/2023	Alethia Young	Director	Sell	11,666	$39.86	$465,006.76	9,067
5/11/2023	Allan Steven Jacobson	Director	Sell	23,000	$55.08	$1,266,840.00	12,348
4/21/2023	Christine Marie Utter	CAO	Sell	4,692	$55.06	$258,341.52	38,059
4/21/2023	Emma Reeve	Director	Sell	4,328	$55.05	$238,256.40	7,200
4/18/2023	Eric Pauwels	Insider	Sell	732	$52.04	$38,093.28	64,805
4/18/2023	Matthew B. Klein	CEO	Sell	1,211	$52.04	$63,020.44	102,645
4/17/2023	David P. Southwell	Director	Sell	11,429	$51.03	$583,221.87	10,500
4/17/2023	Mark Elliott Boulding	VP	Sell	61,923	$51.42	$3,184,080.66	75,378
3/31/2023	David P. Southwell	Director	Sell	2,571	$50.05	$128,678.55	10,500
3/29/2023	Christine Marie Utter	CAO	Sell	4,688	$47.79	$224,039.52	38,059
3/27/2023	Christine Marie Utter	CAO	Sell	26,658	$45.09	$1,202,009.22	38,059
3/27/2023	David P. Southwell	Director	Sell	10,000	$45.10	$451,000.00	10,500
3/27/2023	Emily Luisa Hill	CFO	Sell	7,363	$45.00	$331,335.00	38,925

SEC Filings (Institutional Ownership Changes) for PTC Therapeutics (NASDAQ:PTCT)

Institutional Buying and Selling by Quarter

PTC Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/20/2026	Hsbc Holdings PLC	12,128	$0.93M	0.0%	-93.2%	0.015%
3/17/2026	Rockefeller Capital Management L.P.	405,536	$30.81M	0.1%	-14.4%	0.490%
3/9/2026	Flax Pond Capital LLC	6,000	$0.46M	0.3%	N/A	0.007%
2/24/2026	Pacer Advisors Inc.	235,653	$17.90M	0.0%	-53.2%	0.294%
2/19/2026	Mcguire Capital Advisors Inc.	5,226	$0.40M	0.3%	N/A	0.007%
2/19/2026	Invesco Ltd.	434,285	$32.99M	0.0%	+38.7%	0.541%
2/18/2026	Mercer Global Advisors Inc. ADV	13,431	$1.02M	0.0%	-6.6%	0.017%
2/18/2026	Summit Global Investments	3,186	$0.24M	0.0%	N/A	0.004%
2/18/2026	State of Tennessee Department of Treasury	32,634	$2.47M	0.0%	N/A	0.041%
2/18/2026	Mackenzie Financial Corp	236,909	$18.02M	0.0%	+17.4%	0.295%
2/18/2026	Empowered Funds LLC	250,412	$19.02M	0.2%	+473.0%	0.312%
2/18/2026	Ikarian Capital LLC	118,657	$9.01M	0.7%	-76.0%	0.148%
2/18/2026	VARCOV Co.	2,720	$0.21M	0.1%	N/A	0.003%
2/18/2026	Virtus Investment Advisers LLC	9,033	$0.69M	0.2%	+3.6%	0.011%
2/18/2026	Wellington Management Group LLP	3,867,380	$293.77M	0.1%	-21.4%	4.817%
2/18/2026	Toronto Dominion Bank	4,138,215	$314.34M	0.5%	+27.5%	5.154%
2/18/2026	Tudor Investment Corp ET AL	7,412	$0.56M	0.0%	N/A	0.009%
2/18/2026	Orbimed Advisors LLC	23,200	$1.76M	0.0%	N/A	0.029%
2/18/2026	Millennium Management LLC	22,494	$1.71M	0.0%	-97.9%	0.028%
2/18/2026	Man Group plc	16,185	$1.23M	0.0%	-93.9%	0.020%
2/18/2026	Inspire Investing LLC	6,140	$0.47M	0.0%	-18.3%	0.008%
2/18/2026	Ishara Investments LP	36,000	$2.74M	3.2%	N/A	0.045%
2/18/2026	Janus Henderson Group PLC	4,851,332	$368.59M	0.2%	+28.6%	6.042%
2/18/2026	Gotham Asset Management LLC	16,259	$1.24M	0.0%	-10.0%	0.020%
2/18/2026	Evolve Private Wealth LLC	5,817	$0.44M	0.0%	N/A	0.007%
2/18/2026	Engineers Gate Manager LP	36,709	$2.79M	0.0%	+227.1%	0.046%
2/18/2026	Bridgeway Capital Management LLC	28,100	$2.13M	0.0%	-32.8%	0.035%
2/18/2026	Boothbay Fund Management LLC	39,735	$3.02M	0.0%	-79.5%	0.049%
2/18/2026	Armistice Capital LLC	2,801,869	$212.83M	2.5%	-14.5%	3.490%
2/17/2026	Guggenheim Capital LLC	41,238	$3.13M	0.0%	+145.6%	0.051%
2/17/2026	AQR Capital Management LLC	341,927	$25.97M	0.0%	+3.2%	0.426%
2/17/2026	MPM Bioimpact LLC	430,013	$32.66M	3.7%	-1.9%	0.536%
2/17/2026	Kotler Kevin	5,000	$0.38M	0.1%	N/A	0.006%
2/17/2026	Price T Rowe Associates Inc. MD	460,114	$34.95M	0.0%	+0.4%	0.573%
2/17/2026	Rock Springs Capital Management LP	61,879	$4.70M	0.2%	N/A	0.077%
2/17/2026	Adage Capital Partners GP L.L.C.	141,000	$10.71M	0.0%	-51.5%	0.176%
2/17/2026	Public Employees Retirement System of Ohio	1,658	$0.13M	0.0%	N/A	0.002%
2/17/2026	California State Teachers Retirement System	68,293	$5.19M	0.0%	+5.8%	0.085%
2/17/2026	Russell Investments Group Ltd.	270,748	$20.57M	0.0%	+9.4%	0.337%
2/17/2026	Maryland State Retirement & Pension System	11,742	$0.89M	0.0%	N/A	0.015%
2/17/2026	State of Wisconsin Investment Board	46,775	$3.55M	0.0%	-20.4%	0.058%
2/17/2026	Kemnay Advisory Services Inc.	1,857	$0.14M	0.0%	N/A	0.002%
2/17/2026	Captrust Financial Advisors	3,474	$0.26M	0.0%	N/A	0.004%
2/17/2026	ExodusPoint Capital Management LP	11,057	$0.84M	0.0%	-84.9%	0.014%
2/17/2026	Royal Bank of Canada	6,241	$0.47M	0.0%	-93.7%	0.008%
2/16/2026	Verition Fund Management LLC	20,200	$1.53M	0.0%	-45.5%	0.025%
2/16/2026	Panagora Asset Management Inc.	359,837	$27.33M	0.1%	+3.3%	0.448%
2/16/2026	MML Investors Services LLC	7,151	$0.54M	0.0%	-32.5%	0.009%
2/16/2026	Mariner LLC	12,290	$0.93M	0.0%	+40.5%	0.015%
2/16/2026	Cladis Investment Advisory LLC	4,200	$0.32M	0.2%	-19.2%	0.005%
2/16/2026	Arax Advisory Partners	408	$31K	0.0%	-95.1%	0.001%
2/16/2026	Barclays PLC	220,196	$16.73M	0.0%	-8.1%	0.274%
2/13/2026	FORA Capital LLC	13,925	$1.06M	0.1%	+139.0%	0.017%
2/13/2026	Marshall Wace LLP	247,746	$18.82M	0.0%	+57.1%	0.309%
2/13/2026	The Manufacturers Life Insurance Company	426,506	$32.40M	0.0%	+0.4%	0.531%
2/13/2026	CANADA LIFE ASSURANCE Co	78,150	$5.94M	0.0%	+130.0%	0.097%
2/13/2026	Segall Bryant & Hamill LLC	50,431	$3.83M	0.1%	+34.6%	0.063%
2/13/2026	Bridgewater Associates LP	16,229	$1.23M	0.0%	+35.9%	0.020%
2/13/2026	UMB Bank n.a.	339	$26K	0.0%	N/A	0.000%
2/13/2026	Quarry LP	3,865	$0.29M	0.1%	+1,171.4%	0.005%
2/13/2026	Smartleaf Asset Management LLC	921	$70K	0.0%	+96.4%	0.001%
2/13/2026	Bridgefront Capital LLC	3,185	$0.24M	0.1%	N/A	0.004%
2/13/2026	Advyzon Investment Management LLC	3,543	$0.27M	0.0%	N/A	0.004%
2/13/2026	Morgan Stanley	905,192	$68.76M	0.0%	+115.8%	1.127%
2/13/2026	Schroder Investment Management Group	72,597	$5.53M	0.0%	+112.8%	0.090%
2/13/2026	Public Sector Pension Investment Board	324,636	$24.66M	0.1%	N/A	0.404%
2/13/2026	Rafferty Asset Management LLC	78,507	$5.96M	0.0%	-22.3%	0.098%
2/13/2026	First Trust Advisors LP	155,596	$11.82M	0.0%	+27.7%	0.194%
2/13/2026	Headlands Technologies LLC	4,591	$0.35M	0.0%	N/A	0.006%
2/13/2026	Alyeska Investment Group L.P.	72,307	$5.49M	0.0%	N/A	0.090%
2/13/2026	Charles Schwab Investment Management Inc.	734,933	$55.83M	0.0%	+4.6%	0.915%
2/13/2026	Police & Firemen s Retirement System of New Jersey	21,067	$1.60M	0.0%	-2.1%	0.026%
2/13/2026	Van ECK Associates Corp	2,862	$0.22M	0.0%	N/A	0.004%
2/13/2026	State Street Corp	4,206,126	$319.50M	0.0%	+34.2%	5.239%
2/13/2026	Ieq Capital LLC	35,681	$2.71M	0.0%	+10.4%	0.044%
2/13/2026	Boston Partners	487,977	$37.07M	0.0%	+34.9%	0.608%
2/13/2026	Martingale Asset Management L P	20,115	$1.53M	0.0%	+47.9%	0.025%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	131,893	$10.02M	0.0%	+1.5%	0.164%
2/13/2026	Wells Fargo & Company MN	86,921	$6.60M	0.0%	+69.0%	0.108%
2/13/2026	Lord Abbett & CO. LLC	627,106	$47.64M	0.1%	+65.9%	0.781%
2/13/2026	Castleark Management LLC	96,860	$7.36M	0.2%	N/A	0.121%
2/12/2026	Advisors Asset Management Inc.	7,460	$0.57M	0.0%	N/A	0.009%
2/12/2026	HRT Financial LP	67,064	$5.09M	0.0%	+469.2%	0.084%
2/12/2026	MetLife Investment Management LLC	43,554	$3.31M	0.0%	-3.8%	0.054%
2/12/2026	Cibc World Markets Corp	5,142	$0.39M	0.0%	N/A	0.006%
2/12/2026	Renaissance Technologies LLC	607,589	$46.15M	0.1%	-34.5%	0.757%
2/12/2026	Dimensional Fund Advisors LP	627,092	$47.63M	0.0%	-18.9%	0.781%
2/12/2026	Federated Hermes Inc.	112,566	$8.55M	0.0%	+659.8%	0.140%
2/12/2026	Ensign Peak Advisors Inc	280,572	$21.31M	0.0%	-2.8%	0.349%
2/12/2026	Informed Momentum Co LLC	71,735	$5.45M	0.6%	N/A	0.089%
2/12/2026	New York State Common Retirement Fund	28,915	$2.20M	0.0%	-5.2%	0.036%
2/12/2026	CIBC Private Wealth Group LLC	2,518	$0.19M	0.0%	N/A	0.003%
2/12/2026	Bank of Montreal Can	5,819	$0.44M	0.0%	N/A	0.007%
2/12/2026	Elo Mutual Pension Insurance Co	14,801	$1.12M	0.0%	N/A	0.018%
2/12/2026	Sector Gamma AS	61,923	$4.70M	1.1%	-47.6%	0.077%
2/12/2026	Swiss National Bank	141,065	$10.72M	0.0%	+2.0%	0.176%
2/12/2026	Aviva PLC	4,347	$0.33M	0.0%	-49.6%	0.005%
2/12/2026	Nuveen LLC	699,190	$53.11M	0.0%	-3.1%	0.871%
2/11/2026	Stirlingshire Investments Inc.	3,587	$0.27M	0.2%	N/A	0.004%
2/11/2026	Picton Mahoney Asset Management	2,280	$0.17M	0.0%	N/A	0.003%

Data available starting January 2016

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Today's Range

Now: $65.30

$65.10

$68.20

50 Day Range

MA: $70.70

$62.82

$77.59

52 Week Range

Now: $65.30

$35.95

$87.50

Volume

2,016,889 shs

Average Volume

1,338,002 shs

Market Capitalization

$5.41 billion

P/E Ratio

8.44

Dividend Yield

N/A

Beta

0.51

Who are the company insiders with the largest holdings of PTC Therapeutics?: PTC Therapeutics' top insider shareholders include:
Matthew B Klein (CEO)
Mark Elliott Boulding (VP)
Neil Gregory Almstead (Insider)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Eric Pauwels (CEO)
Eric Pauwels (Insider)
Christine Marie Utter (CAO)
Allan Steven Jacobson (Director)
Glenn Md Phd Steele Jr (Director)
David P Southwell (Director)
Jerome B Zeldis (Director)
Emma Reeve (Director)
Stephanie Okey (Director)
Learn More about top insider investors at PTC Therapeutics.
Who are the major institutional investors of PTC Therapeutics?: PTC Therapeutics' top institutional investors include:
Vanguard Group Inc. — 10.96%
Janus Henderson Group PLC — 6.04%
State Street Corp — 5.24%
Toronto Dominion Bank — 5.15%
Wellington Management Group LLP — 4.82%
Armistice Capital LLC — 3.49%
Learn More about top institutional investors of PTC Therapeutics stock.
Which major investors are selling PTC Therapeutics stock?: During the previous quarter, PTCT stock was sold by these institutional investors:
Wellington Management Group LLP
Millennium Management LLC
Armistice Capital LLC
Pictet Asset Management Holding SA
Ikarian Capital LLC
Renaissance Technologies LLC
Pacer Advisors Inc.
Man Group plc
Within the previous year, company insiders that have sold PTC Therapeutics company stock include:
Matthew B Klein (CEO)
Mark Elliott Boulding (VP)
Neil Gregory Almstead (Insider)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Eric Pauwels (CEO)
Eric Pauwels (Insider)
Christine Marie Utter (CAO)
Allan Steven Jacobson (Director)
Glenn Md Phd Steele Jr (Director)
David P Southwell (Director)
Jerome B Zeldis (Director)
Learn More investors selling PTC Therapeutics stock.
Which major investors are buying PTC Therapeutics stock?: Within the previous quarter, PTCT stock was bought by institutional investors including:
Janus Henderson Group PLC
State Street Corp
Toronto Dominion Bank
BNP Paribas Financial Markets
SG Americas Securities LLC
Vanguard Group Inc.
UBS Group AG
Morgan Stanley